Main Page: Difference between revisions

From Research Wiki
← Older editNewer edit →
Consolidated to ONE table. Added Swedish revenue (allabolag.se). 85 companies.
Added Category, Founded, Revenue columns. 91 companies. Added Denmark/Finland companies.
Line 6: Line 6:


== Companies ==
== Companies ==
All 85 companies: [[:Category:Company]]
All 91 companies: [[:Category:Company]]


{| class="wikitable sortable"
{| class="wikitable sortable"
! Company !! Country !! Focus !! Valuation !! Revenue 2024
! Company !! Country !! Category !! Founded !! Valuation !! Revenue 2024
|-
|-
| [[Actithera]] || Norway || Radiopharmaceutical company developing radioligand therapies for cancer treatment. Radioligand therapy targets cancer cells with radioactive compounds, offering precision treatment with fewer side effects than traditional chemotherapy. || — || —
| [[Actithera]] || Norway || Radiopharma || ~2024 || — || —
|-
|-
| [[Dignio]] || Norway || Remote patient monitoring and digital care platform for chronic disease management. Scalable solution to monitor patients remotely and prevent hospitalizations. || ~€30-50M (est.) || 96.6M NOK
| [[Dignio]] || Norway || Remote monitoring || ~2010 || ~€30-50M (est.) || 96.6M NOK
|-
|-
| [[Dr. Dropin]] || Norway || Private GP platform offering both digital and physical clinics. Democratizing private healthcare access. || ~€30-50M (€19.2M raised) || 24.8M NOK
| [[Dr. Dropin]] || Norway || Digi-physical GP || ~2020 || ~€30-50M (€19.2M raised) || 24.8M NOK
|-
|-
| [[Holberg EEG]] || Norway || AI-based EEG interpretation for neurodiagnostics. Developed autoSCORE AI analysis tool for automated EEG review. || Undisclosed; est. ~€5-15M || 0.4M NOK
| [[Holberg EEG]] || Norway || AI neurodiagnostics || ~2018 || Undisclosed; est. ~€5-15M || 0.4M NOK
|-
|-
| [[Journalia]] || Norway || AI platform to free up healthcare professionals' time by automating administrative tasks in healthcare settings. || $1M (Sep 2025); est. ~€2-5M || 0
| [[Journalia]] || Norway || AI journaling || ~2024 || $1M (Sep 2025); est. ~€2-5M || 0
|-
|-
| [[Lioness Medtech]] || Norway || Norwegian medtech company partnering with Hyperfine to deploy portable MRI brain imaging systems in Norwegian hospitals. || Undisclosed || —
| [[Lioness Medtech]] || Norway || Portable MRI || ~2023 || Undisclosed || —
|-
|-
| [[No Isolation]] || Norway || Communication robots (AV1) for chronically ill children to maintain social connection with school and friends while unable to attend in person. || Undisclosed; est. ~€10-30M || 37.9M NOK
| [[No Isolation]] || Norway || AV1 robots || ~2015 || Undisclosed; est. ~€10-30M || 37.9M NOK
|-
|-
| [[Nolla Health]] || Norway || AI-powered skin health platform combining AI with real doctors. Offers acne treatment and mole scan/skin cancer assessment via mobile app. || $4.5M (Sep 2025); est. ~€5-15M || 0
| [[Nolla Health]] || Norway || AI dermatology || ~2023 || $4.5M (Sep 2025); est. ~€5-15M || 0
|-
|-
| [[Noteless]] || Norway || AI-powered clinical documentation that automatically generates medical notes during patient consultations using speech recognition and NLP. Saves clinicians up to 2 hours per day. || €3.5M Seed (Nov 2025); est. ~€5-15M || 3.3M NOK
| [[Noteless]] || Norway || AI docs || 2023 || €3.5M Seed (Nov 2025); est. ~€5-15M || 3.3M NOK
|-
|-
| [[Acorai]] || Sweden || Non-invasive intracardiac pressure monitor for heart failure management. The device measures pressure inside the heart without invasive catheterization, enabling continuous monitoring of heart failure patients. || ~€20-40M (€4.2M+ raised) || 0
| [[Acorai]] || Sweden || Cardiac monitor || ~2022 || ~€20-40M (€4.2M+ raised) || 0
|-
|-
| [[BOOST Pharma]] || Sweden || Cell therapy for children with osteogenesis imperfecta (genetic bone disease / brittle bone disease). || €3.1M+ (Nov 2025); est. ~€5-15M || —
| [[BOOST Pharma]] || Sweden || Cell therapy || ~2020 || €3.1M+ (Nov 2025); est. ~€5-15M || —
|-
|-
| [[Cellcolabs]] || Sweden || Scalable stem cell manufacturing to lower global stem cell costs by 90%. || ~€30-50M ($12M raised) || 16.7M SEK
| [[Cellcolabs]] || Sweden || Stem cells || ~2021 || ~€30-50M ($12M raised) || 16.7M SEK
|-
|-
| [[Dentio]] || Sweden || AI-powered dental admin solutions — automating clinical documentation and workflow for dentists. || ~€50-100M (a16z backed) || 0
| [[Dentio]] || Sweden || AI dental || ~2024 || ~€50-100M (a16z backed) || 0
|-
|-
| [[Doctrin]] || Sweden || Digital healthcare platform for primary care and specialist consultations. Digital triage and consultation to reduce waiting times. || ~€80-100M (est.) || 43.7M SEK
| [[Doctrin]] || Sweden || Digital primary || ~2016 || ~€80-100M (est.) || 43.7M SEK
|-
|-
| [[Kry / Livi]] || Sweden || Leading European telehealth platform. Video doctor consultations and digital healthcare services. || ~€1.5B (peak €2B, 2021) || 1,233M SEK
| [[Kry / Livi]] || Sweden || Telehealth || 2015 || ~€1.5B (peak €2B, 2021) || 1,233M SEK
|-
|-
| [[Loovi]] || Sweden || Preventive health and longevity platform. Details on product are limited. || €1M (Feb 2026); est. ~€2-5M || —
| [[Loovi]] || Sweden || Preventive health || ~2025 || €1M (Feb 2026); est. ~€2-5M || —
|-
|-
| [[Meela]] || Sweden || Patient-therapist matching platform for mental health. Uses algorithms to match patients with the most suitable therapist based on needs, preferences, and therapeutic approach. || €2.6M Seed (Jul 2024); est. ~€5-10M || 7.5M SEK
| [[Meela]] || Sweden || Therapy matching || ~2024 || €2.6M Seed (Jul 2024); est. ~€5-10M || 7.5M SEK
|-
|-
| [[Min Doktor]] || Sweden || Digital healthcare platform offering online doctor consultations and prescriptions in Sweden. || ~€100M (est.) || N/A
| [[Min Doktor]] || Sweden || Online doctor || 2016 || ~€100M (est.) || —
|-
|-
| [[Mindler]] || Sweden || Digital therapy platform offering cognitive behavioral therapy (CBT) for mental health conditions. || Acquired ieso Digital Health UK for ~£20M+ || 196M SEK
| [[Mindler]] || Sweden || Digital therapy || ~2018 || Acquired ieso Digital Health UK for ~£20M+ || 196M SEK
|-
|-
| [[Neko Health]] || Sweden || AI-powered full-body scanning for preventive health. Comprehensive health screening in ~15 minutes using proprietary sensors and AI. || ~$200M (Series A, 2023) || 24.4M SEK
| [[Neko Health]] || Sweden || AI body scan || 2022 || ~$200M (Series A, 2023) || 24.4M SEK
|-
|-
| [[Nyctea Technologies]] || Sweden || Swedish deeptech startup bringing electrified purification to drug development to accelerate medical innovation. || Undisclosed; early biotech || —
| [[Nyctea Technologies]] || Sweden || Biotech || ~2024 || Undisclosed; early biotech || —
|-
|-
| [[Sakura]] || Sweden || B2B mental health solutions for employers. Employee wellbeing platform. || Pre-seed (Apr 2025); est. ~€1-3M || —
| [[Sakura]] || Sweden || B2B mental health || ~2024 || Pre-seed (Apr 2025); est. ~€1-3M || —
|-
|-
| [[Tandem Health]] || Sweden || AI-native operating system for healthcare providers. Started with clinical documentation, expanding to clinical coding, decision support, and care coordination. Goal: free clinicians from administrative burden. || ~€250M implied (€42.6M Series A, Jun 2025) || 2.7M SEK
| [[Tandem Health]] || Sweden || AI clinical OS || 2023 || ~€250M implied (€42.6M Series A, Jun 2025) || 2.7M SEK
|-
|-
| [[TrialMe]] || Sweden || Fixing the data gap that keeps women out of clinical trials. TrialMe addresses the historical underrepresentation of women in clinical research by developing tools and methodologies to ensure gender-balanced trial participation. || Undisclosed || —
| [[TrialMe]] || Sweden || Femtech || ~2024 || Undisclosed || —
|-
|-
| [[Hemi Health]] || Denmark || Female-led Danish startup raising EUR 4 million to expand migraine and concussion care internationally. || €4M (2025); est. ~€10-20M || —
| [[Corti]] || Denmark || AI assistant || 2016 || ~€200M+ (est.) || —
|-
|-
| [[VentriJect]] || Denmark || Danish medtech startup that secured EUR 1.7 million to expand its cardiorespiratory fitness monitoring device, the Siesmofit system. || €1.7M (Aug 2025); est. ~€5-10M || —
| [[Hemi Health]] || Denmark || Migraine care || ~2024 || €4M (2025); est. ~€10-20M || —
|-
|-
| [[Audicin]] || Finland || Finnish neurowellness startup that raised $1.9M to scale real-time nervous system technology across apps and wearables. Audicin aims to hack recovery while you work by monitoring and modulating the nervous system. || $1.9M (2025); est. ~€5-10M || —
| [[Interhuman AI]] || Denmark || AI intelligence || 2023 || ~€5-10M (est.) || —
|-
|-
| [[Torch]] || Latvia || Latvian medical startup building 'medical memory' for AI. Acquired by OpenAI to integrate medical context and patient history into ChatGPT Health. || Acquired by OpenAI for ~$100M (2025) || —
| [[Teton.ai]] || Denmark || AI monitoring || 2020 || ~€50-80M (est.) || —
|-
|-
| [[Kilo Health]] || Lithuania || Lithuanian digital health company and startup backer that builds, co-founds, and invests in health tech startups globally. Operates a portfolio of digital health products including fasting, keto, and wellness apps. || ~€100-200M (private est.) || —
| [[VentriJect]] || Denmark || Cardiac fitness || ~2022 || €1.7M (Aug 2025); est. ~€5-10M || —
|-
|-
| [[Self.co]] || Lithuania || Lithuanian digital health startup making allergy and food intolerance testing accessible and affordable across Europe. Addresses the problem of allergy misdiagnosis affecting nearly half of Europeans. || €2.56M (2025); est. ~€5-10M || —
| [[AIATELLA]] || Finland || AI imaging || 2020 || ~€5-10M (est.) || —
|-
|-
| [[Caro Health]] || Netherlands || Dutch AI healthtech startup that partnered with U.S.-based HOPCo to expand AI-driven healthcare solutions across Europe and North America. || Undisclosed || —
| [[Audicin]] || Finland || Neurowellness || ~2023 || $1.9M (2025); est. ~€5-10M || —
|-
|-
| [[Delphyr]] || Netherlands || AI platform reducing healthcare administrative workloads by automating clinical documentation and administrative tasks for healthcare providers. || €1.75M (2025); est. ~€3-5M || —
| [[MultivisionDx]] || Finland || AI diagnostics || 2022 || ~€3-5M (est.) || —
|-
|-
| [[Fellos]] || Netherlands || Dutch men's health startup tackling sensitive issues like erectile dysfunction and premature ejaculation through telehealth consultations. || €2M (2025); est. ~€3-5M || —
| [[Oura]] || Finland || Wearables || 2013 || $11B (2025) || —
|-
|-
| [[Guideways]] || Netherlands || Platform that accelerates FDA and CE mark approvals for MedTech companies, reducing the compliance burden that eats up 75% of MedTech budgets. || €1M+ (2025); est. ~€3-5M || —
| [[Torch]] || Latvia || Medical AI || 2023 || Acquired by OpenAI for ~$100M (2025) || —
|-
|-
| [[Healthplus.ai]] || Netherlands || AI-powered health diagnostics platform leveraging machine learning to improve clinical decision-making and patient outcomes. || €2.3M (2025); est. ~€5-10M || —
| [[Kilo Health]] || Lithuania || Health investor || 2018 || ~€100-200M (private est.) || —
|-
|-
| [[OpenUp]] || Netherlands || Employee mental health platform providing on-demand access to psychologists and mental wellbeing tools for companies across Europe. || ~€80-100M implied (€20M round, 2025) || —
| [[Self.co]] || Lithuania || Allergy testing || 2022 || €2.56M (2025); est. ~€5-10M || —
|-
|-
| [[B!LOBA]] || Belgium || B!LOBA is a Belgian company involved in data management and health data solutions. || — || —
| [[Caro Health]] || Netherlands || AI healthtech || 2022 || Undisclosed || —
|-
|-
| [[Mindoo]] || Belgium || AI workforce platform automating hospital intake, clinical scribes, and administrative workflows to reduce workload for hospital and medical staff. || €5M Seed (2025); est. ~€10-20M || —
| [[Delphyr]] || Netherlands || AI admin || 2023 || €1.75M (2025); est. ~€3-5M || —
|-
|-
| [[Sunrise Group]] || Belgium || Digital sleep clinic offering home-based sleep apnea testing and treatment. Uses FDA-cleared wearable device for overnight sleep monitoring and AI-powered analysis. || ~€100-150M implied ($29M round) || —
| [[Fellos]] || Netherlands || Men's health || 2023 || €2M (2025); est. ~€3-5M || —
|-
|-
| [[Ada Health]] || Germany || AI-powered symptom assessment and health guide platform. Uses medical knowledge base and AI to help users understand their health symptoms and navigate to appropriate care. || $100M+ raised; est. ~$300-500M || —
| [[Guideways]] || Netherlands || Regulatory || 2023 || €1M+ (2025); est. ~€3-5M || —
|-
|-
| [[Averbis]] || Germany || Averbis is a German company specializing in NLP (Natural Language Processing) and clinical text mining for healthcare. || — || —
| [[Healthplus.ai]] || Netherlands || AI diagnostics || 2023 || €2.3M (2025); est. ~€5-10M || —
|-
|-
| [[Avi Medical]] || Germany || Tech-enabled primary care clinics providing modern, patient-centered healthcare. Operates multiple clinic locations across Germany combining digital tools with in-person care. || €80M+ raised; est. ~€200-300M || —
| [[OpenUp]] || Netherlands || Employee mental || 2020 || ~€80-100M implied (€20M round, 2025) || —
|-
|-
| [[Cara Care]] || Germany || Digital therapeutic app for irritable bowel syndrome (IBS) and digestive health. DiGA-approved in Germany, prescribed by physicians and reimbursed by health insurers. || — || —
| [[B!LOBA]] || Belgium || Health data || 2020 || — || —
|-
|-
| [[Centogene]] || Germany || Rare disease diagnostics and multiomic data platform leveraging AI for genetic insights. Maintains one of the world's largest rare disease datasets. || Sold operating assets for €8.7M (2025); was Nasdaq-listed || —
| [[Mindoo]] || Belgium || AI hospital ops || 2023 || €5M Seed (2025); est. ~€10-20M || —
|-
|-
| [[Clue]] || Germany || Science-backed period tracking and reproductive health app. One of the most popular cycle tracking apps globally with millions of users. || $40M+ raised; est. ~$100-200M || —
| [[Sunrise Group]] || Belgium || Sleep clinic || 2018 || ~€100-150M implied ($29M round) || —
|-
|-
| [[Fernarzt]] || Germany || German telemedicine platform offering online doctor consultations, e-prescriptions, and remote medical services across Germany. || Established; est. ~€20-40M || —
| [[Ada Health]] || Germany || AI symptom check || 2011 || $100M+ raised; est. ~$300-500M || —
|-
|-
| [[HelloBetter]] || Germany || Digital mental health platform offering evidence-based online therapy programs. Provides DiGA-approved courses for various mental health conditions. || ~€40-60M (€10M Series A) || —
| [[Averbis]] || Germany || NLP || 2000 || — || —
|-
|-
| [[Kaia Health]] || Germany || Digital therapeutic platform for musculoskeletal and COPD conditions using AI motion tracking. DiGA-approved in Germany for back pain therapy. || Acquired by Sword for $285M (2025) || —
| [[Avi Medical]] || Germany || Tech clinics || 2020 || €80M+ raised; est. ~€200-300M || —
|-
|-
| [[Medbelle]] || Germany || Digital hospital platform for surgical care management. Digitizes the entire patient journey from consultation through surgery and recovery. || €25M+ raised; est. ~€50-80M || —
| [[Cara Care]] || Germany || IBS therapy || 2016 || — || —
|-
|-
| [[Selfapy]] || Germany || Digital mental health platform providing online therapy courses for depression and anxiety. DiGA-approved in Germany, prescribed and reimbursed by statutory health insurance. || — || —
| [[Centogene]] || Germany || Rare disease || 2006 || Sold operating assets for €8.7M (2025); was Nasdaq-listed || —
|-
|-
| [[Vara]] || Germany || AI-powered breast cancer screening platform deployed in Greece and multiple European markets. Uses machine learning to improve mammography reading accuracy and reduce false positives. || Multiple rounds; est. ~€50-100M || —
| [[Clue]] || Germany || Women's health || 2013 || $40M+ raised; est. ~$100-200M || —
|-
|-
| [[Viomedo]] || Germany || Platform connecting patients with clinical trials and research studies in Germany. Helps match eligible patients to relevant ongoing clinical research. || Est. ~€5-15M || —
| [[Fernarzt]] || Germany || Telemedicine || 2017 || Established; est. ~€20-40M || —
|-
|-
| [[Wellster]] || Germany || Digital health platform for men's health and chronic condition management, offering telemedicine consultations and treatment plans. || Multiple rounds; est. ~€30-50M || —
| [[HelloBetter]] || Germany || Mental health DiGA || 2015 || ~€40-60M (€10M Series A) || —
|-
|-
| [[Zava]] || Germany || Online doctor consultation and prescription platform operating across Europe. Offers remote consultations, diagnostics, and prescription delivery. || — || —
| [[Kaia Health]] || Germany || Digital MSK || 2016 || Acquired by Sword for $285M (2025) || —
|-
|-
| [[Alan]] || France || Digital health insurance company offering simple, transparent health coverage. One of Europe's most valuable healthtech startups with over 500,000 members. || €5B valuation (2025) || —
| [[Medbelle]] || Germany || Digital surgery || 2016 || €25M+ raised; est. ~€50-80M || —
|-
|-
| [[BioSerenity]] || France || Connected medical devices and digital platform for neurology and cardiology diagnostics. Offers wearable EEG and ECG monitoring with cloud-based analysis. || €40M+ raised; est. ~€80-100M || —
| [[Selfapy]] || Germany || Mental health DiGA || 2016 || — || —
|-
|-
| [[Doctolib]] || France || Leading European online medical appointment booking and telemedicine platform. Dominant in France with 70M+ monthly users and expanding across Europe. || €5.8B valuation (2022) || —
| [[Vara]] || Germany || AI mammography || 2018 || Multiple rounds; est. ~€50-100M || —
|-
|-
| [[Incepto]] || France || AI-powered medical imaging platform deploying radiology AI applications in clinical settings. Provides a marketplace for AI imaging algorithms from multiple vendors. || Est. ~€20-40M || —
| [[Viomedo]] || Germany || Clinical trials || 2016 || Est. ~€5-15M || —
|-
|-
| [[Lifen]] || France || Digital health document management platform connecting healthcare stakeholders. Enables secure document exchange and interoperability between hospitals, labs, and practitioners. || Multiple rounds; est. ~€50-100M || —
| [[Wellster]] || Germany || Men's health || 2020 || Multiple rounds; est. ~€30-50M || —
|-
|-
| [[Mediflash]] || France || Healthcare staffing platform connecting medical professionals with healthcare facilities. Gig-economy approach to solving hospital staffing shortages. || €25M+ raised; est. ~€50-80M || —
| [[Zava]] || Germany || Online doctor || 2000 || — || —
|-
|-
| [[Nabla]] || France || AI clinical assistant that automates medical documentation. Generates clinical notes from doctor-patient conversations using speech recognition and NLP. || $44M raised; est. ~$200M valuation || —
| [[Alan]] || France || Health insurance || 2016 || €5B valuation (2025) || €5B val.
|-
|-
| [[Owkin]] || France || AI-powered drug discovery and development platform using federated learning to train models on distributed hospital data without moving patient records. || $300M+ raised; est. $1B+ valuation || —
| [[BioSerenity]] || France || Wearable diagnostics || 2014 || €40M+ raised; est. ~€80-100M || —
|-
|-
| [[Padoa]] || France || Digital platform for occupational health management. Digitizes workplace health services including medical exams, risk assessments, and employee health monitoring. || €30M+ Series B; est. ~€100-150M || —
| [[Doctolib]] || France || Telemedicine || 2013 || €5.8B valuation (2022) || €5.8B val.
|-
|-
| [[Qare]] || France || Online medical consultations and telemedicine platform for patients in France. Offers video consultations with doctors, specialists, and mental health professionals. || Est. ~€50-100M || —
| [[Incepto]] || France || AI imaging || 2018 || Est. ~€20-40M || —
|-
|-
| [[SeqOne Genomics]] || France || AI-driven genomic analysis platform for precision medicine and clinical diagnostics. Enables rapid interpretation of genomic sequencing data for clinical decision-making. || Series A; est. ~€30-50M || —
| [[Lifen]] || France || Health documents || 2015 || Multiple rounds; est. ~€50-100M || —
|-
|-
| [[Sim&Cure]] || France || Patient-specific simulation software for interventional radiology and aneurysm treatment planning. Enables clinicians to simulate procedures before operating. || — || —
| [[Mediflash]] || France || Healthcare staffing || 2020 || €25M+ raised; est. ~€50-80M || —
|-
|-
| [[Synapse Medicine]] || France || Digital prescription and medication management platform helping healthcare professionals prescribe safely and manage drug interactions. || Series B+; est. ~€50-100M || —
| [[Nabla]] || France || AI clinical docs || 2018 || $44M raised; est. ~$200M valuation || —
|-
|-
| [[Withings]] || France || Connected health devices manufacturer — smartwatches, smart scales, blood pressure monitors, and sleep trackers. Pioneer in consumer health monitoring. || Multiple rounds; est. ~€200-300M || —
| [[Owkin]] || France || AI drug discovery || 2016 || $300M+ raised; est. $1B+ valuation || —
|-
|-
| [[Biorce]] || Spain || AI-driven clinical trials platform accelerating drug development. Uses machine learning to optimize trial design, patient recruitment, and protocol optimization. || ~€200M implied ($52.5M Series A, 2025) || —
| [[Padoa]] || France || Occupational health || 2017 || €30M+ Series B; est. ~€100-150M || —
|-
|-
| [[DFP Research]] || Spain || DFP Research is a Spanish research company participating in EU-funded health data projects. || — || —
| [[Qare]] || France || Telemedicine || 2021 || Est. ~€50-100M || —
|-
|-
| [[Pragmatech]] || Spain || Spanish HealthTech with CE-marked AI software for antibiotic prescribing, helping clinicians make evidence-based antimicrobial stewardship decisions. || €650k (2025); est. ~€1-3M || —
| [[SeqOne Genomics]] || France || AI genomics || 2017 || Series A; est. ~€30-50M || —
|-
|-
| [[Qida]] || Spain || Spain's 'Amazon for aging care' — digital home care network connecting elderly patients with caregivers and home healthcare services. || ~€100-150M implied (€37M raised) || —
| [[Sim&Cure]] || France || Medical simulation || 2014 || — || —
|-
|-
| [[Tucuvi]] || Spain || Spanish healthtech that built LOLA, a voice AI assistant for healthcare that automates patient follow-up calls, reporting up to 80% automation of clinical workflows. || ~€60-80M implied (€17M raised) || —
| [[Synapse Medicine]] || France || E-prescription || 2017 || Series B+; est. ~€50-100M || —
|-
|-
| [[Sword Health]] || Portugal || Leading digital physical therapy and musculoskeletal care platform. Expanded into mental health. One of Portugal's most valuable startups at $4B valuation. || $4B valuation (2025) || —
| [[Withings]] || France || Connected devices || 2008 || Multiple rounds; est. ~€200-300M || —
|-
|-
| [[CiaoDott]] || Italy || Italian startup using AI to solve the medical missed-call crisis, automating patient communication and appointment scheduling for clinics. || €1.5M (2025); est. ~€3-5M || —
| [[Biorce]] || Spain || AI clinical trials || 2019 || ~€200M implied ($52.5M Series A, 2025) || —
|-
|-
| [[Qura]] || Italy || Italian health-tech platform focused on connecting patients with healthcare services through a digital-first approach. || €1.5M pre-seed (2025); est. ~€3-5M || —
| [[DFP Research]] || Spain || Research || N/A || — || —
|-
|-
| [[VoiceMed]] || Italy || AI-powered platform for early detection of chronic respiratory diseases using voice analysis. Running pilot programs in Italian healthcare facilities. || €1M (2025); est. ~€2-5M || —
| [[Pragmatech]] || Spain || AI antibiotics || 2022 || €650k (2025); est. ~€1-3M || —
|-
|-
| [[Advantis Medical Imaging]] || Greece || Greek medical imaging AI company that received FDA clearance for brain MRI analysis software, enabling automated detection of neurological conditions. || FDA-cleared; est. ~€10-20M || —
| [[Qida]] || Spain || Aging care || 2019 || ~€100-150M implied (€37M raised) || —
|-
|-
| [[Doctoranytime]] || Greece || Healthcare marketplace connecting patients with doctors for online and in-person appointments. Originally from Belgium, expanded across Southern Europe including Greece. || €1M+ (2020); est. ~€5-15M || —
| [[Tucuvi]] || Spain || Voice AI || 2020 || ~€60-80M implied (€17M raised) || —
|-
|-
| [[Ontotext]] || Bulgaria || Ontotext is a Bulgarian semantic technology company, a subsidiary of Sirma AI EAD and a leading provider of knowledge graph databases and AI solutions. In 2024, Ontotext merged with Semantic Web Company to create '''Graphwise''', a knowledge graph and AI powerhouse. || — || —
| [[Sword Health]] || Portugal || Digital PT || 2015 || $4B valuation (2025) || $4B val.
|-
|-
| [[DP Innovations]] || Hungary || Winner of EIT Health InnoStars Awards. Health tech innovation from Central/Eastern Europe. || — || —
| [[CiaoDott]] || Italy || ||  || €1.5M (2025); est. ~€3-5M || —
|-
|-
| [[Egnosis]] || Romania || Egnosis is a Romanian health technology company specializing in health data intermediation and digital health solutions. || — || —
| [[Qura]] || Italy || ||  || €1.5M pre-seed (2025); est. ~€3-5M || —
|-
|-
| [[Insilico Medicine]] || Hong Kong || AI-driven drug discovery company using deep learning for target identification, molecule generation, and clinical trial optimization. One of the most established AI pharma companies globally. || Est. $1B+ (AI drug discovery leader) || —
| [[VoiceMed]] || Italy || ||  || €1M (2025); est. ~€2-5M || —
|-
|-
| [[Alma]] || US || Mental health platform providing therapy matching and practice management tools for mental health providers. || — || —
| [[Advantis Medical Imaging]] || Greece || AI brain MRI || 2019 || FDA-cleared; est. ~€10-20M || —
|-
|-
| [[Spring Health]] || US || Comprehensive mental health solution for employers, offering therapy, coaching, and medication management. || — || —
| [[Doctoranytime]] || Greece || Doctor marketplace || 2016 || €1M+ (2020); est. ~€5-15M || —
|-
| [[Ontotext]] || Bulgaria || Semantic tech || 2000 || — || —
|-
| [[DP Innovations]] || Hungary || Health tech || ~2024 || — || —
|-
| [[Egnosis]] || Romania || Health interop || 2018 || — || —
|-
| [[Insilico Medicine]] || Hong Kong || AI drug discovery || 2014 || Est. $1B+ (AI drug discovery leader) || —
|-
| [[Alma]] || US || Mental health || ~2020 || — || —
|-
| [[Spring Health]] || US || Mental health || 2016 || — || —
|}
|}


Revision as of 08:29, 14 April 2026

Research Wiki

News

Companies

All 91 companies: Category:Company

Company Country Category Founded Valuation Revenue 2024
Actithera Norway Radiopharma ~2024 — —
Dignio Norway Remote monitoring ~2010 ~€30-50M (est.) 96.6M NOK
Dr. Dropin Norway Digi-physical GP ~2020 ~€30-50M (€19.2M raised) 24.8M NOK
Holberg EEG Norway AI neurodiagnostics ~2018 Undisclosed; est. ~€5-15M 0.4M NOK
Journalia Norway AI journaling ~2024 $1M (Sep 2025); est. ~€2-5M 0
Lioness Medtech Norway Portable MRI ~2023 Undisclosed —
No Isolation Norway AV1 robots ~2015 Undisclosed; est. ~€10-30M 37.9M NOK
Nolla Health Norway AI dermatology ~2023 $4.5M (Sep 2025); est. ~€5-15M 0
Noteless Norway AI docs 2023 €3.5M Seed (Nov 2025); est. ~€5-15M 3.3M NOK
Acorai Sweden Cardiac monitor ~2022 ~€20-40M (€4.2M+ raised) 0
BOOST Pharma Sweden Cell therapy ~2020 €3.1M+ (Nov 2025); est. ~€5-15M —
Cellcolabs Sweden Stem cells ~2021 ~€30-50M ($12M raised) 16.7M SEK
Dentio Sweden AI dental ~2024 ~€50-100M (a16z backed) 0
Doctrin Sweden Digital primary ~2016 ~€80-100M (est.) 43.7M SEK
Kry / Livi Sweden Telehealth 2015 ~€1.5B (peak €2B, 2021) 1,233M SEK
Loovi Sweden Preventive health ~2025 €1M (Feb 2026); est. ~€2-5M —
Meela Sweden Therapy matching ~2024 €2.6M Seed (Jul 2024); est. ~€5-10M 7.5M SEK
Min Doktor Sweden Online doctor 2016 ~€100M (est.) —
Mindler Sweden Digital therapy ~2018 Acquired ieso Digital Health UK for ~£20M+ 196M SEK
Neko Health Sweden AI body scan 2022 ~$200M (Series A, 2023) 24.4M SEK
Nyctea Technologies Sweden Biotech ~2024 Undisclosed; early biotech —
Sakura Sweden B2B mental health ~2024 Pre-seed (Apr 2025); est. ~€1-3M —
Tandem Health Sweden AI clinical OS 2023 ~€250M implied (€42.6M Series A, Jun 2025) 2.7M SEK
TrialMe Sweden Femtech ~2024 Undisclosed —
Corti Denmark AI assistant 2016 ~€200M+ (est.) —
Hemi Health Denmark Migraine care ~2024 €4M (2025); est. ~€10-20M —
Interhuman AI Denmark AI intelligence 2023 ~€5-10M (est.) —
Teton.ai Denmark AI monitoring 2020 ~€50-80M (est.) —
VentriJect Denmark Cardiac fitness ~2022 €1.7M (Aug 2025); est. ~€5-10M —
AIATELLA Finland AI imaging 2020 ~€5-10M (est.) —
Audicin Finland Neurowellness ~2023 $1.9M (2025); est. ~€5-10M —
MultivisionDx Finland AI diagnostics 2022 ~€3-5M (est.) —
Oura Finland Wearables 2013 $11B (2025) —
Torch Latvia Medical AI 2023 Acquired by OpenAI for ~$100M (2025) —
Kilo Health Lithuania Health investor 2018 ~€100-200M (private est.) —
Self.co Lithuania Allergy testing 2022 €2.56M (2025); est. ~€5-10M —
Caro Health Netherlands AI healthtech 2022 Undisclosed —
Delphyr Netherlands AI admin 2023 €1.75M (2025); est. ~€3-5M —
Fellos Netherlands Men's health 2023 €2M (2025); est. ~€3-5M —
Guideways Netherlands Regulatory 2023 €1M+ (2025); est. ~€3-5M —
Healthplus.ai Netherlands AI diagnostics 2023 €2.3M (2025); est. ~€5-10M —
OpenUp Netherlands Employee mental 2020 ~€80-100M implied (€20M round, 2025) —
B!LOBA Belgium Health data 2020 — —
Mindoo Belgium AI hospital ops 2023 €5M Seed (2025); est. ~€10-20M —
Sunrise Group Belgium Sleep clinic 2018 ~€100-150M implied ($29M round) —
Ada Health Germany AI symptom check 2011 $100M+ raised; est. ~$300-500M —
Averbis Germany NLP 2000 — —
Avi Medical Germany Tech clinics 2020 €80M+ raised; est. ~€200-300M —
Cara Care Germany IBS therapy 2016 — —
Centogene Germany Rare disease 2006 Sold operating assets for €8.7M (2025); was Nasdaq-listed —
Clue Germany Women's health 2013 $40M+ raised; est. ~$100-200M —
Fernarzt Germany Telemedicine 2017 Established; est. ~€20-40M —
HelloBetter Germany Mental health DiGA 2015 ~€40-60M (€10M Series A) —
Kaia Health Germany Digital MSK 2016 Acquired by Sword for $285M (2025) —
Medbelle Germany Digital surgery 2016 €25M+ raised; est. ~€50-80M —
Selfapy Germany Mental health DiGA 2016 — —
Vara Germany AI mammography 2018 Multiple rounds; est. ~€50-100M —
Viomedo Germany Clinical trials 2016 Est. ~€5-15M —
Wellster Germany Men's health 2020 Multiple rounds; est. ~€30-50M —
Zava Germany Online doctor 2000 — —
Alan France Health insurance 2016 €5B valuation (2025) €5B val.
BioSerenity France Wearable diagnostics 2014 €40M+ raised; est. ~€80-100M —
Doctolib France Telemedicine 2013 €5.8B valuation (2022) €5.8B val.
Incepto France AI imaging 2018 Est. ~€20-40M —
Lifen France Health documents 2015 Multiple rounds; est. ~€50-100M —
Mediflash France Healthcare staffing 2020 €25M+ raised; est. ~€50-80M —
Nabla France AI clinical docs 2018 $44M raised; est. ~$200M valuation —
Owkin France AI drug discovery 2016 $300M+ raised; est. $1B+ valuation —
Padoa France Occupational health 2017 €30M+ Series B; est. ~€100-150M —
Qare France Telemedicine 2021 Est. ~€50-100M —
SeqOne Genomics France AI genomics 2017 Series A; est. ~€30-50M —
Sim&Cure France Medical simulation 2014 — —
Synapse Medicine France E-prescription 2017 Series B+; est. ~€50-100M —
Withings France Connected devices 2008 Multiple rounds; est. ~€200-300M —
Biorce Spain AI clinical trials 2019 ~€200M implied ($52.5M Series A, 2025) —
DFP Research Spain Research N/A — —
Pragmatech Spain AI antibiotics 2022 €650k (2025); est. ~€1-3M —
Qida Spain Aging care 2019 ~€100-150M implied (€37M raised) —
Tucuvi Spain Voice AI 2020 ~€60-80M implied (€17M raised) —
Sword Health Portugal Digital PT 2015 $4B valuation (2025) $4B val.
CiaoDott Italy €1.5M (2025); est. ~€3-5M —
Qura Italy €1.5M pre-seed (2025); est. ~€3-5M —
VoiceMed Italy €1M (2025); est. ~€2-5M —
Advantis Medical Imaging Greece AI brain MRI 2019 FDA-cleared; est. ~€10-20M —
Doctoranytime Greece Doctor marketplace 2016 €1M+ (2020); est. ~€5-15M —
Ontotext Bulgaria Semantic tech 2000 — —
DP Innovations Hungary Health tech ~2024 — —
Egnosis Romania Health interop 2018 — —
Insilico Medicine Hong Kong AI drug discovery 2014 Est. $1B+ (AI drug discovery leader) —
Alma US Mental health ~2020 — —
Spring Health US Mental health 2016 — —

Hub: Nordics

Topics

Norway Focus

Projects

Regions

Sources

Retrieved from "https://wiki.stamen.health/index.php?title=Main_Page&oldid=356"